Computer-aided drug design in anti-cancer drug discovery: What have we learnt and what is the way forward?
The escalating prevalence of cancer on a global scale, coupled with the inadequacies of present-day therapies and the emergence of drug-resistant cancer strains, has necessitated the development of additional anticancer drugs. The traditional drug discovery process is long and complex, and the high...
Main Authors: | Opeyemi Iwaloye, Paul Olamide Ottu, Femi Olawale, Olorunfemi Oyewole Babalola, Olusola Olalekan Elekofehinti, Babatomiwa Kikiowo, Abayomi Emmanuel Adegboyega, Henry Nnaemeka Ogbonna, Covenant Femi Adeboboye, Ibukun Mary Folorunso, Aderonke Elizabeth Fakayode, Moses Orimoloye Akinjiyan, Sunday Amos Onikanni, Sergey Shityakov |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Informatics in Medicine Unlocked |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352914823001788 |
Similar Items
-
Immunomodulation: a broad perspective for patients’ survival of COVID-19 infection
by: Covenant Femi Adeboboye, et al.
Published: (2020-07-01) -
Identification of natural inhibitor from Aframomum melegueta targeting survivin and mammalian rapamycin signaling pathway in Kidney Cancer
by: Olusola Olalekan Elekofehinti, et al.
Published: (2023-01-01) -
Saponins in Cancer Treatment: Current Progress and Future Prospects
by: Olusola Olalekan Elekofehinti, et al.
Published: (2021-06-01) -
What is Molecular is not invisible to the eyes
by: Frank Lizaraso Caparó, et al.
Published: (2017-01-01) -
Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease
by: Sergey Shityakov, et al.
Published: (2021-10-01)